Cite
HARVARD Citation
De Meijer, C. et al. (n.d.). 1223 Cost-effectiveness of radium-223 compared to best standard of care, abiraterone acetate and enzalutamide in the treatment of castration resistant prostate cancer in the Netherlands. European journal of cancer. pp. S179-S180. [Online].